CD274 and cancer: Consistently, we also previously reported that the functions of 2 × 105 human CD8 T cells could be significantly inhibited by 25 μg human cancer cell-derived PD-L1-positive sEVs (carrying surface PD-L1 at a level of 0.05 ng per μg of sEVs)1.